Magnetic resonance imaging in diffuse malignant bone marrow diseasesNYMAN, R; REHN, S; GLIMELIUS, B et al.Acta radiologica. Diagnosis. 1987, Vol 28, Num 2, pp 199-205, issn 0567-8056Article

Mutation rate of normal and malignant human lymphocytesRAM SESHADRI; KUTLACA, R. J; TRAINOR, K et al.Cancer research (Baltimore). 1987, Vol 47, Num 2, pp 407-409, issn 0008-5472Article

Modifications de l'état nutritionnel à la phase initiale du traitement des cancers et des hémopathies malignes = Changes in nutritional status of the initial phase of treatment of cancers and malignant blood diseasesLAMISSE, F; MAY, M. A; COUET, C et al.La Revue de médecine interne (Paris). 1987, Vol 8, Num 3, pp 257-261, issn 0248-8663Article

Traitement des hémorragies gastrointestinales dans les hémopathies malignesTAKIMOTO, Y.Yakuri to chiryo. 1986, Vol 14, Num 3, pp 703-712, issn 0386-3603Article

VP-16-213 in the treatment of stage III and IV diffuse large cell lymphomaJACOBS, P; KING, H. S; DENT, D. M et al.Cancer. 1985, Vol 56, Num 5, pp 1006-1013, issn 0008-543XArticle

Hairy cell leukaemia occurring during phenytoin (diphenylhydantoin) treatmentGYTE, G. M. L; RICHMOND, J. E; WILLIAMS, J. R. B et al.Scandinavian journal of haematology. 1985, Vol 35, Num 3, pp 358-362, issn 0036-553XArticle

Naproxen has greater antipyretic effect on Hodgkin's disease-related fever than on other tumours or infectionGEISLER, C; GØTZCHE, P. C; HANSEN, S. S et al.Scandinavian journal of haematology. 1985, Vol 35, Num 3, pp 325-328, issn 0036-553XArticle

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkins lymphomasPEDERSEN-BJERGAARD, J; ERSBØLL, J; NISSEN, N. I et al.Annals of internal medicine. 1985, Vol 103, Num 2, pp 195-200, issn 0003-4819Article

Semi-micro adaptation of a 4-day differential staining cytotoxicity (DISC) assay for determining the in-vitro chemosensitivity of haematological malignanciesBIRD, M. C; BOSANQUET, A. G; FORSKITT, S et al.Leukemia research. 1986, Vol 10, Num 4, pp 445-449, issn 0145-2126Article

Leukaemia in benzene workers: a retrospective cohort studyYIN, S.-N; LI, G.-L; WU, H.-N et al.British journal of industrial medicine. 1987, Vol 44, Num 2, pp 124-128, issn 0007-1072Article

Enhancement of granulopoiesis by lithium carbonate in a patient with hairy cell leukemiaLEVINE, M. A; TOBACK, A. C.The American journal of medicine. 1987, Vol 82, Num 1, pp 146-148, issn 0002-9343Article

Update on haematologic malignancyJACOBS, P.Central african journal of medicine. 1986, Vol 32, Num 4, issn 0008-9176, 100Article

Proceedings/Current and future aspects on the clinical use of Ara-C in leukemia, symposium: 3 rd. European conference on clinical oncology and cancer nursing, Stockholm, June 19, 1985GAHRTON, G.Scandinavian journal of haematology. Supplementum. 1986, Vol 36, Num 44, issn 0080-6722, 74 p.Conference Proceedings

Primary cutaneous lymphoplasmacytic lymphomaMARTI, R. M; ESTRACH, T; PALOU, J et al.Journal of the American Academy of Dermatology. 1987, Vol 16, Num 5, pp 1106-1110, issn 0190-9622, 2Article

Les lymphomes malins cutanés = Cutaneous malignant lymphomaBELAICH, S.La Revue du praticien (Paris). 1987, Vol 37, Num 25, pp 1419-1476, issn 0035-2640, 50 p.Article

Histiocytoses X de l'enfant. Revue de 25 cas = Histiocytosis X in children. Report of 25 casesMARANDIAN, M. H; EMAMI, A; RAKCHAN, M et al.Revue de pédiatrie (Paris). 1987, Vol 23, Num 4, pp 169-176, issn 0035-1644, 6 p.Article

Response rate and survival in myeloma patients receiving prednisone aloneMCINTYRE, O. R; PAJAK, T. F; KYLE, R. A et al.Medical and pediatric oncology. 1985, Vol 13, Num 5, pp 239-243, issn 0098-1532Article

Favorable response to aggressive chemotherapy in a patient with primary plasma cell leukemiaLISHNER, M; LANG, R; JUTRIN, I et al.Acta haematologica. 1985, Vol 74, Num 1, pp 49-51, issn 0001-5792Article

Presumed intraocular Hodgkin's diseaseBISHOP, J. E; SALMONSEN, P. C.Annals of ophthalmology (Birmingham). 1985, Vol 17, Num 9, pp 589-592, issn 0003-4886Article

The prophylaxis of infection in patients with malignant diseaseGRANT PRENTICE, H; HANN, I. M; GROB, J.-P et al.Clinics in oncology. 1985, Vol 4, Num 3, pp 435-460, issn 0261-9873Article

Hematological malignanciesMELLSTEDT, Hakan; BARISTA, Ibrahim; DIMOPOULOS, Meletios et al.Annals of oncology. 2006, Vol 17, issn 0923-7534, x135-x159, SUP10Conference Paper

Antiangiogenic therapy in hematologic malignancies : HaematologyMOEHLER, T. M; HILLENGASS, J; GOLDSCHMIDT, H et al.Current pharmaceutical design. 2004, Vol 10, Num 11, pp 1221-1234, issn 1381-6128, 14 p.Article

Cytogénétique et hémopathies malignes (à l'exception des lymphomes) = Cytogenetics and malignant hemopathyFENAUX, P; LAI, J. L; KERCKAERT, J. P et al.Lille médical (1987). 1989, Vol 29, Num 1, pp 27-31, 5 p.Article

Les lymphomes malins non hodgkiniens chez le sujet âgé. A propos de 34 observations = Non-Hodgkin lymphomas in elderly patients. A study of 34 casesLEDERLIN, P; BOMAN, F; WITZ, F et al.Annales médicales de Nancy et de l'Est. 1991, Vol 30, Num 2, pp 159-161, issn 0221-3796, 3 p.Article

13-cis retinoic acid treatment of myelodysplastic syndromesKERNDRUP, G; BENDIX-HANSEN, K; PEDERSEN, B et al.Leukemia research. 1987, Vol 11, Num 1, pp 7-16, issn 0145-2126Article